Abeona Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | -235.5% | – | – | – | – | – | -161,200.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +31.7% | +23.5% | +42.5% | +67.0% | +31.7% | +9.4% | +30.9% | +19.8% | +46.3% | +348.4% | -63.2% | -90.3% | +2.4% | -8.1% | -2.1% | +79.8% | -99.3% | +266.7% | +4,909.1% | +49.7% | -10.2% | +218.5% | +267.7% | -35.5% | -20.3% | +2.5% | -30.1% | -9.1% | +22.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +25.2% | +5.0% | -63.4% | +12.6% | +197.3% | +234.7% | +10.6% | +22.5% | +49.9% | -7.1% | -0.6% | +8.9% | -65.8% | +56.3% | +39.0% | +62.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -80.7% | +1.3% | -6.5% | +67.2% | -2.8% | +472.1% | -21.2% | – | – | – | – | |
| – | -923.1% | – | -120.4% | – | -50.2% | -613.8% | – | – | – | -0.1% | -48.1% | -52.7% | +401.8% | -160.3% | – | – | – | -87.4% | -1,648.2% | – | – | – | -151.0% | – | -1,217.7% | – | – | – | – | |
| – | -57.9% | +525.0% | -95.0% | +1,340.0% | +481.9% | -3.8% | +14.6% | -52.2% | -87.3% | -89.3% | +500.0% | +416.7% | -97.8% | +250.0% | +471.4% | -67.5% | -84.6% | +15,300.0% | +0.0% | +68.5% | +65.7% | +2,166.7% | -66.6% | -79.5% | +210.7% | -96.9% | +154.6% | +639.0% | +226.0% | |
| – | +384.2% | -45.7% | +7.0% | +16,223.4% | – | -26.9% | +124.6% | -80.9% | +742.8% | -126.0% | +41.6% | -97.4% | -98.9% | +600.0% | +471.4% | -67.5% | -84.6% | – | +0.0% | -115.3% | +65.7% | +9,793.7% | – | -239.6% | – | -136.3% | – | -18,965.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +331.6% | +104.9% | +61.3% | +17.7% | -99.1% | +399,451.4% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -257.6% | – | +42,337.9% | -5.5% | +265.6% | +117.2% | -94.1% | +227.4% | -99.0% | -100.0% | – | -99.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -200.0% | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | -100.0% | |
| – | -102.5% | – | -37.9% | +973.3% | -97.9% | -112.3% | +422.7% | – | -142.8% | – | +38.6% | -67.5% | -92.5% | +7,326.3% | -76.9% | -38.1% | -98.5% | +43,717.2% | +180.6% | +19.3% | +117.2% | -94.1% | +1,979.6% | -98.3% | +1,184.1% | +73.7% | -14.2% | +181.0% | -75.0% | |
| – | -190.7% | – | -156.2% | – | -113.1% | – | – | – | -236.1% | – | +923.8% | -149.2% | – | – | -171.2% | – | – | +39,528.6% | +157.9% | +1.3% | +136.5% | -273.0% | – | -205.2% | – | -196.1% | – | +3,370.3% | +516.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -237.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.